Dustin A. Deming MD

Dustin A. Deming, MD, is the ACI/Schwenn Family Associate Professor at the University of Wisconsin School of Medicine and Public Health in the Departments of Medicine and Oncology, and Carbone Cancer Center (UWCCC). He is a gastrointestinal medical oncologist with a subspecialty focus in colorectal cancer and is a rectal cancer survivor himself. He is the co-leader of the UWCCC Developmental Therapeutics program and the UWCCC Precision Medicine Molecular Tumor Board. He is the ECOG-ACRIN chair of the colorectal and anal cancer Working group and the co-chair of the Big Ten Cancer Research Consortium GI committee. Dr. Deming currently serves as a member of the NCCN Colon/Rectal/Anal Cancers Panel.

Dr. Deming earned his medical degree from University of Wisconsin School of Medicine and Public Health. He completed a residency in internal medicine, and a fellowship in medical oncology from University of Wisconsin Hospital and Clinics. He went on to complete a research fellowship at University of Wisconsin-Madison.

Dr. Deming’s NIH-funded laboratory research aims to develop innovative treatment strategies for cancers through a better understanding of how the molecular profile and tumor microenvironment of cancers alter therapeutic response. Dr. Deming also leads a number of active clinical trials sponsored by the NCI and pharmaceutical partners.